𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Bone marrow microvessel density is a prognostic factor for survival in patients with multiple myeloma

✍ Scribed by O. Sezer; K. Niemöller; J. Eucker; C. Jakob; O. Kaufmann; I. Zavrski; M. Dietel; K. Possinger

Publisher
Springer
Year
2000
Tongue
English
Weight
161 KB
Volume
79
Category
Article
ISSN
0939-5555

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Monocytosis is an adverse prognostic fac
Monocytosis is an adverse prognostic factor for survival in younger patients with primary myelofibrosis
✍ M.A. Elliott; S. Verstovsek; D. Dingli; S.M. Schwager; R.A. Mesa; C.Y. Li; A. Te 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 297 KB

We recently developed a modified Dupriez prognostic scoring system (PSS) that effectively discriminated between high-, intermediate-, and low-risk young patients (age < or =60 years) with primary myelofibrosis (PMF) based on the respective presence of none, one, or two or more of the following param

Circulating angiopoietin-1 to angiopoiet
Circulating angiopoietin-1 to angiopoietin-2 ratio is an independent prognostic factor for survival in newly diagnosed patients with multiple myeloma who received therapy with novel antimyeloma agents
✍ Evangelos Terpos; Konstantinos Anargyrou; Eirini Katodritou; Efstathios Kastriti 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 French ⚖ 456 KB 👁 1 views

## Abstract The circulating levels of several angiogenic cytokines [angiopoietin‐1 (Ang‐1), angiopoietin‐2 (Ang‐2), vascular endothelial growth factor (VEGF), angiogenin and basic fibroblast growth factor (bFGF)] were evaluated in 174 consecutive patients with newly diagnosed, symptomatic, multiple